OSCR Oscar Health, Inc. Class A Common Stock
关于 Oscar Health, Inc. Class A Common Stock 公司概况(来自维基百科)
Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems.
阅读更多
Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems.
History
2012–2015
According to the company, it was founded in 2012 by Mario Schlosser, Joshua Kushner, and Kevin Nazemi, who were classmates at Harvard Business School. Mother Jones reported in March 2020 that Joshua and his brother Jared owned the firm's parent company, Thrive Partners III, at the time of its incorporation in 2013. Oscar began selling insurance for 2013, the same year that the Affordable Care Act exchanges and individual mandate went into effect for the 2014 plan year. In its first year, Oscar secured 16,000 members. In 2015, Oscar expanded coverage to New Jersey and grew to about 40,000 members.
2016
Oscar had 145,000 members in New York, New Jersey, California, and Texas in 2016. The firm expanded its operations to Tempe, Arizona, in August that year, where it decided to locate its Concierge teams, their name for their member services model. On August 23, Oscar announced it would be exiting the New Jersey Marketplace at the end of 2016, citing uncertainties in the market that would make it challenging "to operate effectively and continue to deliver access to quality healthcare." Oscar also announced that it would halve the size of its provider network in New York amidst rising premiums in order to "gain more control over pricing and patient experience".
In November 2016, the firm opened the Oscar Center in partnership with Mount Sinai Health System. Located in Brooklyn Heights, next to the Jay Street–MetroTech station, the Oscar Center had a primary care practice only available to Oscar policyholders, with a doctor, nurse practitioner, and a behavioral health specialist. It also hosted free classes for members, such as yoga classes or classes for expectant mothers. On March 13, 2020, Oscar closed the Oscar Center "until further notice."
2017
On April 25, 2017, Oscar announced its entrance into the small group insurance market, offering health plans in New York. On June 15, 2017, Oscar announced its partnership with Cleveland Clinic to offer individual health insurance plans to consumers in five counties in Northeastern Ohio.
On June 21, 2017, Oscar announced its intention to expand to additional markets in 2018 in areas of Tennessee, Ohio, Texas, New Jersey and California. On July 12, 2017, Oscar announced that it would be selling small group insurance in the Nashville metro area to companies with up to 50 employees through a strategic partnership with Humana.
A report by the New York Times in October 2017 speculated that Oscar Health had ties to Saudi Arabia. That month, Jared and Joshua Kushner visited Saudi Arabia's Crown Prince Mohammed bin Salman within days of each other. Despite Jared severing ties with Thrive Partners when he began working for the Trump administration, these coordinated visits raised questions about his ability to be impartial on Saudi affairs. Five months after Joshua's visit to Saudi Arabia in October 2017, Oscar Health announced a $165 million round of financing.
While a spokesman for Kushner said that Oscar Health's management didn't know of direct investment by the Saudis, he declined to disclose if Saudis had invested in Thrive funds. He only confirmed that Thrive hadn't received money from any Saudi parties since the presidential election. In May 2018, Jared Kushner disclosed $8.2 million in capital gains from Thrive funds.
2020–present
In January 2020, Oscar announced a partnership with Cigna to bring health insurance plans to small businesses. The partnership, Cigna + Oscar, will "launch in select markets in 2020 and plan to expand the partnership over time."
As of June 2020, Oscar had sold individual health insurance plans, both directly and through health insurance marketplaces, in New York, Texas and California. Oscar sells Medicare Advantage plans in New York City and Houston, Texas. Mario Schlosser is the company's CEO, after serving as Co-CEO with Nazemi until the latter's departure in early 2015. While Kushner does not hold a formal role in Oscar's daily operations, he remains a major shareholder and Schlosser confirmed (as of 2017) that he has "significant input in multiple aspects of the company like strategy, hiring, and marketing."
Oscar Health raised $1.2 billion on March 3, 2021, after an IPO.
Oscar Health reported 1.1 million members across its platform, which equates to 1 in 13 ACA exchange-based enrollees. The company announced it would exit the Arkansas and Colorado markets for plan year 2023.
Mario Schlosser steps down as CEO on April 3, 2023, transitioning to President of Technology. Mark Bertolini takes over as CEO. [1]
In 2025, Oscar Health was ranked 437th by revenue on the Fortune 500 list and 42nd within the healthcare sector in the same rankings.
Marketing and brand
Oscar Health has run marketing campaigns on the New York City Subway. Bloomberg News reported the advertising campaigns feature cartoons suggesting "an easier way of getting medical care." AdWeek described Oscar Health's print ads as featuring "whimsical, animated characters".
In 2015, AdWeek reported that Oscar was airing its first television campaign targeted at the demographics of "new parents who are too frazzled to shop for health insurance." The ad launched on network stations in New Jersey and New York areas, cable, movie theaters located in New Jersey and in advertising within the Spotify app.
In 2016, Oscar ran a subway ad campaign with an educational bent around what the problems are with the American healthcare system.
Finances
Funding
Oscar has raised capital through a series of funding rounds. Its investors include Thrive Capital, General Catalyst Partners, Khosla Ventures, CapitalG, and Fidelity Investments.
During the May 2014 Series A round, Peter Thiel's Founders Fund led the series investing $30 million. By the close of Series A, Forbes reported the valuation of the company at $800 million.
During the 2015 Series B round, Oscar Health raised $145 million, bringing the total capital raised to $300 million, thus valuing the company at $1.5 billion. Series B investors included Formation 8, Horizons Ventures, Wellington Management Company, and Goldman Sachs.
In September 2015, Oscar announced a funding round with Google Ventures and Google Capital, valuing the company at $1.75 billion.
During the 2016 Series C round, Oscar raised $400 million led by Fidelity Investments, with secondary participation from previous investors, with a reported valuation of $2.7 billion. In 2018, Alphabet invested $375 million in Oscar Health. As of 2019, the company had raised $1.3 billion, and was valued at $3.2 billion.
In June 2020, Oscar raised $225 million in funding, in which the funding round saw participation from previous investors and also new investors, namely Baillie Gifford and Coatue.
Revenue
In 2014, New York magazine reported that as of May 2014, Oscar Health had 16,000 subscribers enrolled in its insurance program producing an estimated $72 million. In 2015, Forbes reported that Oscar Health had 40,000 subscribers with an average subscriber paying annual fees of $4,500, placing Oscar Health's revenue estimates at $180 million.
Vox reported that in 2015, Oscar Health lost $92.4 million in New York as the firm's analytical models failed to accurately forecast "the people who signed up for coverage were sicker than the company had expected."
By 2016, Oscar Health had 135,000 subscribers, with roughly half residing in New York State.
In February 2017, Bloomberg reported that Oscar had lost $204.9 million in 2016.
In May 2017, Bloomberg reported that Oscar's first quarter loss had narrowed by nearly half, writing that the company was "beginning to get a handle on its medical costs." In August 2017, Bloomberg also reported that Oscar had posted a $57.6 million loss in the first half of 2017, down from the $83 million lost posted the year prior.
In December 2017, TechCrunch reported that Oscar would expect to generate $1 billion in revenue and enroll 250,000 in 2018.
In January 2020, TechCrunch reported that Oscar served 400,000 members and expected to bring in $2 billion by the end of the year.
Headquarters and offices
Oscar's headquarters are located in Tribeca, New York City. They also have a technology outpost in Los Angeles and a member services operation in Tempe, Arizona.
来源:维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗
OSCR 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
OSCR 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
10年表现 收入、净利润、利润率和每股收益趋势
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
财务健康 债务、流动性、偿付能力 — 资产负债表强度
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
资本效率 资产周转率、库存周转率、应收账款周转率
OSCR 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
- 强烈买入 2 10.5%
- 买入 7 36.8%
- 持有 9 47.4%
- 卖出 1 5.3%
- 强烈卖出 0 0.0%
12个月价格目标
10 位分析师 · 2026-08-15收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $1.10 | $0.39 | 0.71% |
| 2026年3月31日 | $2.07 | $1.21 | 0.86% |
| 2025年12月31日 | $-1.24 | $-0.91 | -0.33% |
| 2025年9月30日 | $-0.53 | $-0.57 | 0.04% |
| 2025年6月30日 | $-0.89 | $-0.47 | -0.42% |
| 2025年3月31日 | $0.92 | $0.81 | 0.11% |
同行比较(GICS 子行业) 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| OSCR | — | -8.5 | 27.5% | -3.8% | -44.5% | — |
| PRU | — | — | — | — | — | — |
| PFG | $19.18B | 16.8 | -3.1% | 7.6% | 10.3% | — |
| UNM | — | — | — | — | — | — |
| GL | $12.90B | 9.9 | 3.7% | 19.4% | 20.4% | — |
| PRI | $8.22B | 11.3 | 6.6% | 22.8% | 31.9% | — |
| LNC | $8.46B | 7.6 | -1.2% | 6.5% | 12.3% | — |
| CNO | $4.01B | 18.5 | 0.85% | 5.1% | 8.9% | — |
| GNW | $3.54B | 16.7 | 0.08% | 3.0% | 2.6% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 13
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B | $463M | |
| SG&A Expense | $2.05B | $1.76B | $1.43B | $1.26B | $265M | $167M | |
| Operating Income | $-396M | $57M | $-236M | $-590M | $-544M | $-402M | |
| Interest Expense | · | · | $25M | $23M | $5M | $4M | |
| Other Non-op | $-23M | $-105.0K | $-7M | $2M | $-1M | · | |
| Pretax Income | $-437M | $33M | $-267M | $-610M | $-571M | $-406M | |
| Income Tax | $6M | $7M | $3M | $-523.0K | $846.0K | $1M | |
| Net Income | $-443M | $25M | $-271M | $-606M | $-573M | $-407M | |
| EPS (Basic) | $-1.69 | $0.11 | $-1.22 | $-2.85 | $-3.20 | $-14.16 | |
| EPS (Diluted) | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 | $-14.16 | |
| Shares (Basic) | 262,388,000 | 240,386,000 | 221,655,000 | 212,475,000 | 178,967,056 | 29,263,424 | |
| Shares (Diluted) | 262,388,000 | 265,853,000 | 221,655,000 | 212,475,000 | 178,967,056 | 29,263,424 | |
| EBITDA | $-367M | $89M | $-205M | · | $-530M | · |
资产负债表 23
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.77B | $1.53B | $1.87B | $1.56B | $1.10B | $826M | |
| Short-term Investments | · | $624M | $690M | · | · | · | |
| Receivables | $363M | · | · | · | · | · | |
| Other Current Assets | $24M | $21M | $7M | $6M | $4M | · | |
| Current Assets | $4.61B | $2.85B | $3.06B | $4.12B | $2.31B | $1.87B | |
| PP&E (Net) | $88M | $67M | $62M | $60M | $47M | $36M | |
| PP&E (Gross) | $230M | $181M | $150M | $117M | $89M | $63M | |
| Accum. Depreciation | $142M | $114M | $88M | $57M | $42M | $27M | |
| Other Non-current Assets | $120M | $82M | $83M | $95M | $97M | $13M | |
| Total Assets | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B | $2.27B | |
| Accounts Payable | $507M | $432M | $273M | $298M | $235M | $138M | |
| Current Liabilities | $4.86B | $3.46B | $2.43B | $3.26B | $1.85B | $1.67B | |
| Capital Leases | $52M | $61M | $67M | $72M | $77M | · | |
| Other Non-current Liabilities | $52M | $61M | $68M | $72M | $77M | $0 | |
| Total Liabilities | $5.34B | $3.82B | $2.80B | $3.63B | $1.93B | $1.82B | |
| Total Debt | $430M | $300M | $299M | · | $0 | · | |
| Common Stock | · | · | · | · | · | $2.0K | |
| Paid-in Capital | $4.26B | $3.87B | $3.68B | $3.51B | $3.39B | $133M | |
| Retained Earnings | $-3.29B | $-2.85B | $-2.88B | $-2.61B | $-2.00B | $-1.43B | |
| Treasury Stock | $3M | $3M | $3M | $3M | $3M | $3M | |
| AOCI | $18M | $-2M | $1M | $-10M | $-4M | $879.0K | |
| Stockholders' Equity | $978M | $1.01B | $804M | $890M | $1.39B | $-1.30B | |
| Liabilities + Equity | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B | $2.27B |
现金流 16
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $29M | $32M | $31M | $15M | $15M | $11M | |
| Stock-based Comp | $88M | $110M | $160M | $112M | $86M | $36M | |
| Deferred Tax | $2M | $-2M | $58.0K | $-165.0K | $-101.0K | $-67.0K | |
| Other Non-cash | $1.42B | $813M | $-192M | · | $290M | · | |
| Operating Cash Flow | $1.09B | $978M | $-272M | $380M | $-182M | $223M | |
| CapEx | $36M | $28M | $26M | $29M | $26M | $14M | |
| Investing Cash Flow | $-241M | $-1.39B | $577M | $-227M | $-775M | $-345M | |
| Debt Issued | $410M | $0 | $0 | $305M | $0 | $147M | |
| Net Debt Issued | $410M | $0 | $0 | · | · | · | |
| Stock Repurchased | · | · | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | $0 | · | |
| Financing Cash Flow | $399M | $68M | $6M | $301M | $1.24B | $612M | |
| Net Change in Cash | $1.25B | $-341M | $311M | $455M | $282M | $490M | |
| Taxes Paid | $18M | $674.0K | $2M | $2M | $697.0K | $2M | |
| Free Cash Flow | $1.06B | $950M | $-298M | · | $-208M | · | |
| Levered FCF | · | · | $-323M | · | $-212M | · |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -3.4% | 0.62% | -4.0% | · | -29.6% | · | |
| Net Margin | -3.8% | 0.28% | -4.6% | · | -31.1% | · | |
| Pretax Margin | -3.7% | 0.36% | -4.6% | · | -31.0% | · | |
| EBITDA Margin | -3.1% | 0.97% | -3.5% | · | -28.8% | · | |
| ROA | -7.9% | 0.60% | -6.7% | · | -20.5% | · | |
| ROE | -44.5% | 2.8% | -32.0% | · | -36.7% | · | |
| ROIC | -28.5% | 3.4% | -21.6% | · | -39.3% | · |
流动性与偿付能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.8 | 1.3 | · | 1.2 | · | |
| Quick Ratio | 0.6 | 0.6 | 0.8 | · | 0.6 | · | |
| Debt / Equity | 0.4 | 0.3 | 0.4 | · | 0.0 | · | |
| LT Debt / Equity | 0.4 | 0.3 | 0.4 | · | 0.0 | · | |
| Interest Coverage | · | · | -9.6 | · | -115.4 | · |
效率 1
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.1 | 2.2 | 1.4 | · | 0.7 | · |
增长率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 27.5% | 56.5% | 47.9% | 115.6% | 297.3% | · | |
| Revenue CAGR 3Y | 43.5% | 70.9% | 133.1% | · | · | · | |
| Revenue CAGR 5Y | 90.8% | · | · | · | · | · |
估值 (TTM) 4
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B | · | |
| Net Income TTM | $-443M | $25M | $-271M | $-606M | $-573M | · | |
| P/E | -8.5 | 134.4 | -7.5 | -0.9 | -2.5 | · | |
| Earnings Yield | -11.8% | 0.74% | -13.3% | -115.9% | -40.8% | · |
损益表 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.88B | $4.65B | $2.81B | $2.99B | $2.86B | $3.05B | $2.39B | $2.42B | $2.22B | $2.14B | $1.43B | $1.44B | $1.52B | $1.47B | $995M | $978M | |
| SG&A Expense | $691M | $706M | $511M | $522M | $534M | $483M | $466M | $460M | $435M | $394M | $364M | $326M | $337M | $399M | $1.02B | $79M | |
| Operating Income | $389M | $704M | $-334M | $-129M | $-230M | $297M | $-148M | $-48M | $68M | $186M | $-145M | $-58M | $-7M | $-25M | $-222M | $-192M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $6M | · | $6M | $6M | $6M | · | $6M | |
| Other Non-op | $-915.0K | $71.0K | $-20M | $-3M | $3M | $-3M | $68.0K | $2M | $-872.0K | $-1M | $1M | $-414.0K | $-2M | $-6M | $1M | $3M | |
| Pretax Income | $383M | $699M | $-353M | $-139M | $-234M | $288M | $-154M | $-52M | $61M | $178M | $-151M | $-65M | $-14M | $-38M | $-227M | $-195M | |
| Income Tax | $21M | $20M | $-247.0K | $-2M | $-5M | $13M | $-404.0K | $2M | $5M | $996.0K | $-806.0K | $915.0K | $1M | $2M | $-715.0K | $-2M | |
| Net Income | $362M | $679M | $-353M | $-137M | $-228M | $275M | $-154M | $-55M | $56M | $177M | $-150M | $-65M | $-16M | $-40M | $-226M | $-193M | |
| EPS (Basic) | $1.20 | $2.28 | $-1.37 | $-0.53 | $-0.89 | $1.10 | $-0.68 | $-0.22 | $0.24 | $0.77 | $-0.68 | $-0.29 | $-0.07 | $-0.18 | $-1.05 | $-0.91 | |
| EPS (Diluted) | $1.10 | $2.07 | $-1.19 | $-0.53 | $-0.89 | $0.92 | $-0.50 | $-0.22 | $0.20 | $0.62 | $-0.68 | $-0.29 | $-0.07 | $-0.18 | $-1.05 | $-0.91 | |
| Shares (Basic) | 302,220,000 | 298,184,000 | -503,695,000 | 259,273,000 | 255,531,000 | 251,279,000 | -472,835,000 | 243,106,000 | 238,672,000 | 231,443,000 | -437,757,000 | 223,099,000 | 219,400,000 | 216,913,000 | -422,206,923 | 212,822,733 | |
| Shares (Diluted) | 333,432,000 | 329,751,000 | -558,354,000 | 259,273,000 | 255,531,000 | 305,938,000 | -575,014,000 | 243,106,000 | 303,965,000 | 293,796,000 | -437,757,000 | 223,099,000 | 219,400,000 | 216,913,000 | -422,206,923 | 212,822,733 | |
| EBITDA | $389M | $711M | · | $-129M | $-230M | $304M | · | $-48M | $68M | $193M | · | $-58M | $-7M | $-20M | · | $-192M |
资产负债表 21
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.08B | $4.81B | $2.77B | $2.15B | $2.60B | $2.24B | $1.53B | $1.21B | $2.27B | $2.23B | $1.87B | $1.40B | $2.32B | $2.11B | $1.56B | $2.11B | |
| Receivables | $380M | $587M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Current Assets | $60M | $26M | $24M | $29M | $30M | $23M | $21M | $21M | $16M | $9M | · | $8M | $8M | $11M | · | $16M | |
| Current Assets | $9.37B | $7.78B | $4.61B | $3.76B | $4.31B | $3.77B | $2.85B | $2.37B | $3.36B | $3.50B | · | $2.99B | $4.19B | $4.13B | · | $3.93B | |
| PP&E (Net) | $101M | $94M | $88M | $83M | $78M | $72M | $67M | $67M | $64M | $61M | · | $62M | $63M | $64M | · | $56M | |
| PP&E (Gross) | · | · | $230M | · | · | · | $181M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $142M | · | · | · | $114M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $122M | $123M | $120M | $121M | $116M | $94M | $82M | $84M | $87M | $87M | · | $89M | $92M | $95M | · | $97M | |
| Total Assets | $11.23B | $9.29B | $6.33B | $5.75B | $6.38B | $5.84B | $4.84B | $4.48B | $5.01B | $4.42B | · | $3.35B | $4.56B | $4.48B | · | $4.31B | |
| Accounts Payable | $526M | $506M | $650M | $557M | $584M | $634M | $432M | $395M | $348M | $303M | · | $260M | $262M | $299M | · | $252M | |
| Current Liabilities | $8.69B | $7.14B | $4.86B | $3.98B | $4.87B | $4.15B | $3.46B | $2.95B | $3.50B | $3.02B | · | $2.06B | $3.24B | $3.18B | · | $2.85B | |
| Capital Leases | · | · | $52M | · | · | · | $61M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $50M | $51M | $52M | $56M | $57M | $59M | $61M | $64M | $65M | $66M | · | $69M | $70M | $71M | · | $74M | |
| Total Liabilities | $9.17B | $7.62B | $5.34B | $4.72B | $5.22B | $4.51B | $3.82B | $3.32B | $3.87B | $3.38B | · | $2.43B | $3.61B | $3.55B | · | $3.22B | |
| Total Debt | $432M | $431M | · | $686M | $300M | $300M | · | $299M | $299M | $299M | · | $299M | $298M | $298M | · | $298M | |
| Paid-in Capital | $4.32B | $4.28B | $4.26B | $3.95B | $3.95B | $3.90B | $3.87B | $3.84B | $3.79B | $3.74B | · | $3.65B | $3.62B | $3.58B | · | $3.48B | |
| Retained Earnings | $-2.25B | $-2.62B | $-3.29B | $-2.94B | $-2.80B | $-2.58B | $-2.85B | $-2.70B | $-2.64B | $-2.70B | · | $-2.73B | $-2.66B | $-2.65B | · | $-2.38B | |
| Treasury Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| AOCI | $-8M | $5M | $18M | $16M | $14M | $10M | $-2M | $26M | $-3M | $-3M | · | $-4M | $-7M | $-4M | · | $-14M | |
| Stockholders' Equity | $2.05B | $1.66B | $978M | $1.02B | $1.16B | $1.33B | $1.01B | $1.16B | $1.14B | $1.03B | · | $919M | $950M | $930M | · | $1.08B | |
| Liabilities + Equity | $11.23B | $9.29B | $6.33B | $5.75B | $6.38B | $5.84B | $4.84B | $4.48B | $5.01B | $4.42B | · | $3.35B | $4.56B | $4.48B | · | $4.31B |
现金流 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $7M | $8M | $7M | $7M | $7M | $9M | $8M | $8M | $8M | $8M | $9M | $9M | $5M | $4M | $4M | |
| Stock-based Comp | $21M | $16M | $18M | $20M | $24M | $25M | $26M | $29M | $29M | $26M | $26M | $29M | $33M | $71M | $29M | $29M | |
| Deferred Tax | $-2M | $-6M | $3M | $-175.0K | $-36.0K | $36.0K | $-2M | $-119.0K | $130.0K | $-79.0K | $-37.0K | $69.0K | $209.0K | $-183.0K | $-171.0K | $2.0K | |
| Other Non-cash | · | $1.92B | · | · | · | $572M | · | · | · | $423M | · | · | · | $378M | · | · | |
| Operating Cash Flow | $2.09B | $2.62B | $672M | $-965M | $509M | $879M | $347M | $-500M | $497M | $634M | $297M | $-1.15B | $166M | $415M | $151M | $-548M | |
| CapEx | $12M | $9M | $9M | $9M | $9M | $9M | $7M | $8M | $8M | $6M | $6M | $6M | $6M | $7M | $7M | $10M | |
| Investing Cash Flow | $-2.83B | $-590M | $-49M | $150M | $-168M | $-174M | $-31M | $-578M | $-478M | $-301M | $172M | $225M | $44M | $136M | $-707M | $299M | |
| Debt Issued | · | · | $0 | · | · | · | $0 | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $13M | $-4M | $8M | $364M | $22M | $5M | $4M | $19M | $19M | $27M | $1M | $2M | $3M | $506.0K | $527.0K | $423.0K | |
| Net Change in Cash | $-729M | $2.03B | $631M | $-451M | $363M | $709M | $319M | $-1.06B | $38M | $361M | $470M | $-922M | $212M | $551M | $-555M | $-249M | |
| Taxes Paid | $1M | $44.0K | $19.0K | $2M | $15M | $0 | $38.0K | $552.0K | · | · | $1M | $600.0K | · | · | $233.0K | $555.0K | |
| Free Cash Flow | · | $2.61B | · | · | · | $870M | · | · | · | $628M | · | · | · | $407M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $623M | · | · | · | $401M | · | · |
盈利能力 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 8.0% | 15.2% | · | -4.3% | -8.1% | 9.8% | · | -2.0% | 3.1% | 8.7% | · | -4.0% | -0.43% | -1.7% | · | -19.7% | |
| Net Margin | 7.4% | 14.6% | · | -4.6% | -8.0% | 9.0% | · | -2.2% | 2.5% | 8.3% | · | -4.5% | -1.0% | -2.7% | · | -19.7% | |
| Pretax Margin | 7.8% | 15.0% | · | -4.7% | -8.2% | 9.5% | · | -2.2% | 2.8% | 8.3% | · | -4.5% | -0.94% | -2.6% | · | -20.0% | |
| EBITDA Margin | 8.0% | 15.3% | · | -4.3% | -8.1% | 10.0% | · | -2.0% | 3.1% | 9.0% | · | -4.0% | -0.43% | -1.4% | · | -19.7% | |
| ROA | 4.1% | 9.0% | · | -2.7% | -4.0% | 5.4% | · | -1.4% | 1.2% | 4.0% | · | -1.7% | -0.33% | -0.90% | · | -5.2% | |
| ROE | 22.5% | 45.3% | · | -12.6% | -19.9% | 23.3% | · | -5.2% | 5.4% | 18.1% | · | -6.5% | -1.4% | -3.5% | · | -14.6% | |
| ROIC | 14.8% | 32.7% | · | -7.5% | -15.5% | 17.4% | · | -3.4% | 4.4% | 13.9% | · | -4.9% | -0.57% | -2.2% | · | -13.8% |
流动性与偿付能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 1.0 | 1.2 | · | 1.5 | 1.3 | 1.3 | · | 1.4 | |
| Quick Ratio | 0.5 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.4 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Debt / Equity | 0.2 | 0.3 | · | 0.7 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| LT Debt / Equity | 0.2 | 0.3 | · | 0.7 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 31.4 | · | -9.5 | -1.1 | -4.1 | · | -31.4 |
效率 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | · | 0.6 | 0.5 | 0.6 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 25.7 | 15.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 4
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $15.38B | $13.54B | · | $11.32B | $10.55B | $9.83B | · | $8.23B | $7.32B | $6.57B | · | $5.41B | $4.99B | $4.44B | · | $3.41B | |
| Net Income TTM | $675M | $588M | · | $-145M | $49M | $454M | · | $114M | $153M | $57M | · | $-314M | $-360M | $-420M | · | $-592M | |
| P/E | 16.3 | 7.3 | · | -26.3 | 2144.0 | 8.6 | · | 68.4 | 34.4 | 185.9 | · | -3.8 | -4.8 | -3.3 | · | -1.8 | |
| Earnings Yield | 6.1% | 13.7% | · | -3.8% | 0.05% | 11.6% | · | 1.5% | 2.9% | 0.54% | · | -26.0% | -21.0% | -30.3% | · | -56.5% |
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B |
| 营业利润率 % | -3.4% | 0.62% | -4.0% | — | -29.6% |
| 净收入 | $-443M | $25M | $-271M | $-606M | $-573M |
| 稀释后每股收益 (EPS) | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.4 | 0.3 | 0.4 | — | 0.0 |
| 流动比率 | 0.9 | 0.8 | 1.3 | — | 1.2 |
| 速动比率 | 0.6 | 0.6 | 0.8 | — | 0.6 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $1.06B | $950M | $-298M | — | $-208M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存,并会跟随您浏览所有股票。
机构持有人 (13F) 463 家申报者 · $4.5B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 134 (+60 与上一季度对比) | 45 (-19 与上一季度对比) | 141 (+17 与上一季度对比) | 107 (-4 与上一季度对比) | +16.8M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD PORTFOLIO MANAGEMENT LLC | $314559172 | 11029424 | 7.01% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $301725543 | 10579437 | 6.73% | 股份 |
| D. E. Shaw & Co., Inc. | $259880743 | 9112228 | 5.79% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $258255502 | 9055242 | 5.76% | 股份 |
| Thrive Capital Management, LLC | $180919957 | 6343617 | 4.03% | 股份 |
| STATE STREET CORP | $165454531 | 5801351 | 3.69% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $162917648 | 5712400 | 3.63% | 买入期权 |
| GEODE CAPITAL MANAGEMENT, LLC | $141980956 | 4977203 | 3.17% | 股份 |
| FMR LLC | $138622458 | 4860535 | 3.09% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $115097850 | 4035689 | 2.57% | 股份 |
| BIT Capital GmbH | $97480134 | 3417957 | 2.17% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $94434740 | 3311177 | 2.11% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $93673940 | 3284500 | 2.09% | 股份 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $86282012 | 3025316 | 1.92% | 股份 |
| JANE STREET GROUP, LLC | $74631792 | 2616823 | 1.66% | 股份 |
| GLYNN CAPITAL MANAGEMENT LLC | $73462615 | 2575828 | 1.64% | 股份 |
| CITADEL ADVISORS LLC | $72469320 | 2541000 | 1.62% | 买入期权 |
| WOLVERINE ASSET MANAGEMENT LLC | $61825656 | 2167800 | 1.38% | 卖出期权 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $60458493 | 2119863 | 1.35% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $55351616 | 1940800 | 1.23% | 卖出期权 |
| JANE STREET GROUP, LLC | $53968396 | 1892300 | 1.20% | 买入期权 |
| BlackBarn Capital Partners LP | $49910000 | 1750000 | 1.11% | 卖出期权 |
| BNP PARIBAS FINANCIAL MARKETS | $48660710 | 1706196 | 1.08% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $45996029 | 1612764 | 1.03% | 股份 |
| CITADEL ADVISORS LLC | $44459828 | 1558900 | 0.99% | 卖出期权 |
| STATE OF MICHIGAN RETIREMENT SYSTEM | $41354000 | 1450000 | 0.92% | 股份 |
| BANK OF AMERICA CORP /DE/ | $36176793 | 1268471 | 0.81% | 股份 |
| Assenagon Asset Management S.A. | $35592732 | 1247992 | 0.79% | 股份 |
| TWO SIGMA ADVISERS, LP | $35534136 | 2472800 | 0.79% | 股份 |
| JANE STREET GROUP, LLC | $33796200 | 1185000 | 0.75% | 卖出期权 |
| GROUP ONE TRADING LLC | $32744154 | 1148112 | 0.73% | 股份 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $31200652 | 1093992 | 0.70% | 股份 |
| Qube Research & Technologies Ltd | $30913940 | 1083939 | 0.69% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $29055948 | 1018792 | 0.65% | 股份 |
| GILDER GAGNON HOWE & CO LLC | $28576515 | 1001982 | 0.64% | 股份 |
| GOLDMAN SACHS GROUP INC | $26322819 | 922960 | 0.59% | 股份 |
| Walleye Capital LLC | $23243058 | 814974 | 0.52% | 股份 |
| Point72 Asset Management, L.P. | $22809212 | 799762 | 0.51% | 股份 |
| Walleye Trading LLC | $22744700 | 797500 | 0.51% | 买入期权 |
| FEDERATED HERMES, INC. | $22241550 | 779858 | 0.50% | 股份 |
| Walleye Trading LLC | $20594292 | 722100 | 0.46% | 卖出期权 |
| Balyasny Asset Management L.P. | $20211240 | 708669 | 0.45% | 股份 |
| WOLVERINE TRADING, LLC | $19244780 | 1006000 | 0.43% | 买入期权 |
| MILLENNIUM MANAGEMENT LLC | $18292101 | 641378 | 0.41% | 股份 |
| Halter Ferguson Financial Inc. | $17882240 | 627007 | 0.40% | 股份 |
| CITADEL ADVISORS LLC | $17044921 | 597648 | 0.38% | 股份 |
| Walleye Trading LLC | $15952833 | 559356 | 0.36% | 股份 |
| Caption Management, LLC | $15723076 | 551300 | 0.35% | 卖出期权 |
| WOLVERINE TRADING, LLC | $14846793 | 776100 | 0.33% | 卖出期权 |
| CAPITAL FUND MANAGEMENT S.A. | $14807327 | 519191 | 0.33% | 股份 |
| PFM Health Sciences, LP | $14802336 | 519016 | 0.33% | 股份 |
| CANADA PENSION PLAN INVESTMENT BOARD | $14317040 | 502000 | 0.32% | 股份 |
| WELLS FARGO & COMPANY/MN | $14301981 | 501472 | 0.32% | 股份 |
| Eurizon Capital SGR S.p.A. | $13987854 | 490380 | 0.31% | 股份 |
| RPG Investment Advisory, LLC | $13981017 | 490218 | 0.31% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $13977652 | 490100 | 0.31% | 买入期权 |
| Caption Management, LLC | $13769456 | 482800 | 0.31% | 买入期权 |
| Alphabet Inc. | $13746298 | 481988 | 0.31% | 股份 |
| Swiss National Bank | $13501368 | 473400 | 0.30% | 股份 |
| CREDIT AGRICOLE S A | $13119286 | 460003 | 0.29% | 股份 |
| RBF Capital, LLC | $12822706 | 449604 | 0.29% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $12802628 | 448900 | 0.29% | 卖出期权 |
| Trexquant Investment LP | $12674259 | 444399 | 0.28% | 股份 |
| BlackRock, Inc. | $12343114 | 432788 | 0.28% | 股份 |
| IMC-Chicago, LLC | $12036581 | 422040 | 0.27% | 股份 |
| FORA Capital, LLC | $11957021 | 419030 | 0.27% | 股份 |
| PERCEPTIVE ADVISORS LLC | $11408000 | 400000 | 0.25% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $11327203 | 397167 | 0.25% | 股份 |
| Rhenman & Partners Asset Management AB | $11179840 | 392000 | 0.25% | 股份 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $10799925 | 378679 | 0.24% | 股份 |
| UBS Group AG | $10607358 | 371927 | 0.24% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $10027661 | 351601 | 0.22% | 股份 |
| ARDSLEY ADVISORY PARTNERS LP | $9982000 | 350000 | 0.22% | 股份 |
| VICTORY CAPITAL MANAGEMENT INC | $9924475 | 347983 | 0.22% | 股份 |
| Fiduciary Alliance LLC | $9802210 | 343696 | 0.22% | 股份 |
| BCS Private Wealth Management, Inc. | $9665000 | 338885 | 0.22% | 股份 |
| SIMPLEX TRADING, LLC | $9283516 | 325509 | 0.21% | 股份 |
| Squarepoint Ops LLC | $9166214 | 321396 | 0.20% | 股份 |
| SEB Asset Management AB | $9085456 | 318565 | 0.20% | 股份 |
| MARSHALL WACE, LLP | $9052762 | 317418 | 0.20% | 股份 |
| Squarepoint Ops LLC | $8906796 | 312300 | 0.20% | 买入期权 |
| BARCLAYS PLC | $8827711 | 309527 | 0.20% | 股份 |
| Engineers Gate Manager LP | $8802185 | 308632 | 0.20% | 股份 |
| TOWLE & CO | $8801186 | 308597 | 0.20% | 股份 |
| RHUMBLINE ADVISERS | $8563598 | 300267 | 0.19% | 股份 |
| PRUDENTIAL FINANCIAL INC | $8412544 | 294970 | 0.19% | 股份 |
| FIRST TRUST ADVISORS LP | $8152727 | 285860 | 0.18% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $7939968 | 278400 | 0.18% | 买入期权 |
| FRED ALGER MANAGEMENT, LLC | $7777290 | 272696 | 0.17% | 股份 |
| TORONTO DOMINION BANK | $7632066 | 267604 | 0.17% | 股份 |
| BANK OF MONTREAL /CAN/ | $7383828 | 258900 | 0.16% | 卖出期权 |
| General Equity Holdings LP | $6844800 | 240000 | 0.15% | 股份 |
| TD Asset Management Inc | $6561311 | 230060 | 0.15% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $6509690 | 228250 | 0.15% | 股份 |
| OSAIC HOLDINGS, INC. | $6398318 | 224346 | 0.14% | 股份 |
| AMERIPRISE FINANCIAL INC | $6363383 | 223120 | 0.14% | 股份 |
| Squarepoint Ops LLC | $6203100 | 217500 | 0.14% | 卖出期权 |
| Public Sector Pension Investment Board | $6120392 | 214600 | 0.14% | 股份 |
| Bridgewater Associates, LP | $6094838 | 213704 | 0.14% | 股份 |
| NORGES BANK | $5741390 | 201311 | 0.13% | 股份 |
公司内部人士 21 位内幕人士 · 10 位高管 · 12 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Mark T Bertolini | Chief Executive Officer | 2026年6月30日 S | 7751570 | 1 | 8 | $-58759399 |
| Richard Scott Blackley | Chief Financial Officer | 2026年6月2日 S | 1074977 | 0 | 1 | $-493628 |
| Janet Liang | President, Oscar Insurance | 2026年6月2日 S | 259057 | 0 | 1 | $-194356 |
| Meghan V. Joyce | Chief Operating Officer | 2021年9月1日 M | 34669 | 0 | 0 | $0 |
| Victoria Baltrus | Chief Accounting Officer | 2026年6月2日 S | 214589 | 0 | 1 | $-23718 |
| Adam Mcananey | Chief Legal Officer | 2026年6月2日 S | 218096 | 0 | 1 | $-153593 |
| Joshua Kushner | Co-Founder and Vice Chairman | 2024年11月21日 P | 6343617 | 0 | 0 | $0 |
| Dennis Weaver | Chief Clinical Officer | 2021年9月1日 M | 5323 | 0 | 0 | $0 |
| Alessandrea C. Quane | EVP, Chief Insurance Officer | 2021年8月31日 A | — | 0 | 0 | $0 |
| Joel Klein | Chief Policy & Strat. Officer | 2021年3月5日 A | 0 | 0 | 0 | $0 |
| William Gassen | 董事 | 2026年7月9日 A | 82840 | 0 | 0 | $0 |
| David Plouffe | 董事 | 2026年7月9日 A | 137121 | 0 | 0 | $0 |
| Sid Sankaran | 董事 | 2026年7月9日 A | 22609 | 0 | 0 | $0 |
| Mario Schlosser | 董事 | 2026年7月1日 C | 0 | 0 | 16 | $-32199014 |
| Laura W Lang | 董事 | 2026年6月4日 A | 82840 | 0 | 0 | $0 |
| Vanessa Ames Wittman | 董事 | 2026年6月4日 A | 137121 | 0 | 0 | $0 |
| Jeffery H Boyd | 董事 | 2026年4月9日 A | — | 0 | 0 | $0 |
| Elbert O. Robinson Jr. | 董事 | 2021年3月5日 A | 50000 | 0 | 0 | $0 |
| Teri List-Stoll | 董事 | 2021年3月5日 A | 50000 | 0 | 0 | $0 |
| Jr Charles E Phillips | 董事 | 2021年3月5日 A | 50000 | 0 | 0 | $0 |
| Ari Fischel | — | 2021年3月5日 A | 0 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Thrive Capital Partners II, L.P. (2), Thrive Partners II GP, LLC (2), Thrive Capital Partners III, L.P. (2), Claremount TW, L.P. (2), Thrive Partners III GP, LLC (2), Thrive Capital Partners V, L.P. (2), Claremount V Associates, L.P. (2), Thrive Partners V GP, LLC (2), Thrive Capital Partners VI Growth, L.P. (2), Claremount VI Associates, L.P. (2), Thrive Partners VI GP, LLC (2), Thrive Capital Partners VII Growth, L.P. (2), Thrive Partners VII Growth GP, LLC (2), Claremount VII Associates, L.P. (2), Thrive Partners VII GP, LLC (2), Joshua Kushner (2) ×4 申报 | 2024年11月13日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 64 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| HEAL · Global X Funds | 4.61% | 51902 NS | 2026年5月31日 | N-PORT |
| ABLS · Abacus FCF ETF Trust | 3.73% | 2476 NS | 2026年4月30日 | N-PORT |
| CBLS · Elevation Series Trust | 2.79% | 80448 NS | 2026年4月30日 | N-PORT |
| CBSE · Elevation Series Trust | 2.79% | 72369 NS | 2026年4月30日 | N-PORT |
| RNIN · EA Series Trust | 1.77% | 146523 NS | 2026年4月30日 | N-PORT |
| AVUV · AMERICAN CENTURY ETF TRUST | 0.53% | 6454468 NS | 2026年5月31日 | N-PORT |
| CLSE · Trust for Professional Managers | 0.48% | 132126 NS | 2026年5月31日 | N-PORT |
| OASC · Unified Series Trust | 0.25% | 9324 NS | 2026年5月31日 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.19% | 74299 NS | 2026年4月30日 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0.18% | 7801 NS | 2026年4月30日 | N-PORT |
| FYC · First Trust Exchange-Traded Alpha... | 0.18% | 99887 NS | 2026年4月30日 | N-PORT |
| RSSL · Global X Funds | 0.11% | 87779 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.11% | 9555 NS | 2026年5月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.11% | 798894 NS | 2026年4月30日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.10% | 1045927 NS | 2026年5月31日 | N-PORT |
| AVLV · AMERICAN CENTURY ETF TRUST | 0.10% | 576130 NS | 2026年5月31日 | N-PORT |
| FYX · First Trust Exchange-Traded Alpha... | 0.09% | 60366 NS | 2026年4月30日 | N-PORT |
| UWM · ProShares Trust | 0.07% | 7474 NS | 2026年5月31日 | N-PORT |
| URTY · ProShares Trust | 0.05% | 7563 NS | 2026年5月31日 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0.05% | 5330 NS | 2026年5月31日 | N-PORT |
| FNCL · FIDELITY COVINGTON TRUST | 0.04% | 52605 NS | 2026年4月30日 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.04% | 169 NS | 2026年5月31日 | N-PORT |
| FAD · First Trust Exchange-Traded Alpha... | 0.04% | 9312 NS | 2026年4月30日 | N-PORT |
| TILT · FlexShares Trust | 0.03% | 38192 NS | 2026年4月30日 | N-PORT |
| AVMV · AMERICAN CENTURY ETF TRUST | 0.03% | 8235 NS | 2026年5月31日 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.03% | 164245 NS | 2026年5月31日 | N-PORT |
| FNDA · SCHWAB STRATEGIC TRUST | 0.03% | 103995 NS | 2026年5月31日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.02% | 7591 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.02% | 190 NS | 2026年5月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.02% | 416676 NS | 2026年4月30日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.02% | 18514 NS | 2026年4月30日 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0.02% | 2932 NS | 2026年5月31日 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0.01% | 3086 NS | 2026年5月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 20151 NS | 2026年4月30日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 1983 NS | 2026年4月30日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.01% | 48264 NS | 2026年4月30日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.01% | 126382 NS | 2026年5月31日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.01% | 67852 NS | 2026年4月30日 | N-PORT |
| AVLC · AMERICAN CENTURY ETF TRUST | 0.00% | 1834 NS | 2026年5月31日 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0.00% | 956 NS | 2026年5月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VB · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VBK · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VT · VANGUARD INTERNATIONAL EQUITY IND... | — | — | 2026年7月15日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| ITOT · iShares Trust | — | — | 2026年8月5日 | 每日 |
| IWV · iShares Trust | — | — | 2026年8月18日 | 每日 |